IRIS
BALESTRIERI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.649
NA - Nord America 808
EU - Europa 354
SA - Sud America 208
Continente sconosciuto - Info sul continente non disponibili 53
AF - Africa 23
OC - Oceania 3
Totale 3.098
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 993
US - Stati Uniti d'America 749
CN - Cina 252
IT - Italia 182
BR - Brasile 152
VN - Vietnam 137
HK - Hong Kong 112
BD - Bangladesh 71
FR - Francia 45
GB - Regno Unito 39
DE - Germania 28
MX - Messico 25
CA - Canada 22
AR - Argentina 19
IN - India 17
NL - Olanda 13
EC - Ecuador 12
ID - Indonesia 11
RU - Federazione Russa 10
CO - Colombia 8
PL - Polonia 7
ZA - Sudafrica 7
JP - Giappone 6
PK - Pakistan 6
UA - Ucraina 6
ES - Italia 5
IQ - Iraq 5
PH - Filippine 5
TR - Turchia 5
IR - Iran 4
PE - Perù 4
PY - Paraguay 4
SA - Arabia Saudita 4
TN - Tunisia 4
VE - Venezuela 4
AU - Australia 3
AZ - Azerbaigian 3
CL - Cile 3
CZ - Repubblica Ceca 3
MY - Malesia 3
SE - Svezia 3
UZ - Uzbekistan 3
AM - Armenia 2
AT - Austria 2
BO - Bolivia 2
BW - Botswana 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
FI - Finlandia 2
JO - Giordania 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
SI - Slovenia 2
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
ME - Montenegro 1
MG - Madagascar 1
MQ - Martinica 1
RO - Romania 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
Totale 3.046
Salva come PNG Salva come JPEG
Città #
San Jose 235
Singapore 186
Ashburn 134
Hong Kong 107
Rome 107
Beijing 83
Hefei 68
Council Bluffs 54
Ho Chi Minh City 51
Columbus 43
Lauterbourg 38
Boardman 35
Hanoi 35
London 30
Dallas 29
Shanghai 22
Santa Clara 19
Mexico City 15
New York 15
São Paulo 14
Los Angeles 13
Amsterdam 7
Munich 7
Warsaw 7
Brooklyn 6
Milan 6
Nuremberg 6
Rio de Janeiro 6
San Francisco 6
Seattle 6
Toronto 6
Buffalo 5
Chicago 5
Quito 5
Tokyo 5
Boydton 4
Brasília 4
Buenos Aires 4
Catania 4
Charlotte 4
Da Nang 4
Orem 4
Pune 4
Turin 4
Atlanta 3
Bauru 3
Biên Hòa 3
Bắc Giang 3
Cagliari 3
Dhaka 3
Guarulhos 3
Hamburg 3
Johannesburg 3
Lima 3
Markham 3
Naples 3
Paris 3
Phoenix 3
Stockholm 3
Amman 2
Apodaca 2
Asunción 2
Atibaia 2
Baghdad 2
Baku 2
Banī Suwayf 2
Bari 2
Barquisimeto 2
Berlin 2
Bogotá 2
Boston 2
Brno 2
Bắc Ninh 2
Canberra 2
Canela 2
Caracas 2
Caxias do Sul 2
Chennai 2
Cotia 2
Curitiba 2
Dagenham 2
Formosa 2
Frankfurt am Main 2
Guiyang 2
Haiphong 2
Hưng Yên 2
Itapevi 2
Jeddah 2
Kuala Lumpur 2
La Paz 2
Las Vegas 2
Limeira 2
Liverpool 2
Ljubljana 2
Magé 2
Maicao 2
Maitengwe 2
Medellín 2
Mississauga 2
Montreal 2
Totale 1.579
Salva come PNG Salva come JPEG
Nome #
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 242
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 231
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 142
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 139
Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients 122
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease 101
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 100
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 91
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC) 88
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study 76
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 74
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 73
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study 73
Psychological distress in inflammatory bowel disease 73
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 72
Upadacitinib in Patients With Difficult-to-Treat Crohn’s Disease 69
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 69
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 64
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 63
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 63
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study 60
Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy 57
Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter Study 57
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study 56
Adalimumab in active ulcerative colitis: A "real-life" observational study 54
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 53
Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus 51
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 49
Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients 49
Nutritional aspects in inflammatory bowel diseases 48
Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia 48
High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients 47
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame 46
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study 46
Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responder to proton pump inhibitors 46
Reflux Patterns and Role of Impedance-pH Variables in Predicting PPI Response in Patients With Suspected GERD-Related Chronic Cough 45
Role of Overweight and Obesity in Gastrointestinal Disease 43
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 41
Role of Mixed Reflux and Hypomotility with Delayed Reflux Clearance in Patients with Non-cardiac Chest Pain 40
Understanding the relationship between esophageal motor disorders and reflux disease 39
REFLUX PATTERN AND ROLE OF IMPEDANCE-PH VARIABLES IN PREDICTING PPI RESPONSE IN PATIENTS WITH SUSPECTED GERD-RELATED CHRONIC COUGH 36
Patients With Extra-Esophageal Symptoms, Compared to NERD Patients With Typical Symptoms and Healthy Volunteers, Arc Characterized by a Higher Number of Reflux Episodes and Higher Proportion of Weakly Acidic and Mixed Reflux 32
Therapeutic drug monitoring is more cost-effective than a clinically based approach in the management of loss of response to infliximab in inflammatory bowel disease: An observational multicentre study 30
Totale 3.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.508
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 4 0 0 0 0 0 0 0 0 28
2022/202310 0 0 0 0 1 0 0 0 1 0 8 0
2023/202494 4 11 3 5 6 37 3 6 0 7 9 3
2024/20251.031 22 8 37 3 11 23 23 3 72 71 301 457
2025/20261.789 159 116 173 272 80 74 345 98 165 133 85 89
2026/2027142 29 113 0 0 0 0 0 0 0 0 0 0
Totale 3.098